Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Eligard (Leuprolide Acetate) Injectable Suspension
Company:  ATRIX Laboratories, Inc.
Application No.:  21-343
Approval Date: 1/23/2002


Date created: January 18, 2006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.